Co-Authors
This is a "connection" page, showing publications co-authored by Chiara Agrati and Emanuele Nicastri.
Connection Strength
2.619
-
Expansion of Myeloid Derived Suppressor Cells Contributes to Platelet Activation by L-Arginine Deprivation during SARS-CoV-2 Infection. Cells. 2021 08 17; 10(8).
Score: 0.241
-
Immunogenicity and safety of BNT162b2 COVID-19 vaccine in a chronic lymphocytic leukaemia patient. J Cell Mol Med. 2021 May 25.
Score: 0.237
-
Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis. Eur J Clin Pharmacol. 2021 Oct; 77(10):1583-1585.
Score: 0.236
-
Elevated P-Selectin in Severe Covid-19: Considerations for Therapeutic Options. Mediterr J Hematol Infect Dis. 2021; 13(1):e2021016.
Score: 0.233
-
The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients. Int J Infect Dis. 2021 Apr; 105:49-53.
Score: 0.232
-
An Inflammatory Profile Correlates With Decreased Frequency of Cytotoxic Cells in Coronavirus Disease 2019. Clin Infect Dis. 2020 11 19; 71(16):2272-2275.
Score: 0.229
-
Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome. Cell Death Dis. 2020 10 27; 11(10):921.
Score: 0.228
-
Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19). Cell Death Differ. 2020 11; 27(11):3196-3207.
Score: 0.222
-
Human Zika infection induces a reduction of IFN-? producing CD4 T-cells and a parallel expansion of effector Vd2 T-cells. Sci Rep. 2017 07 24; 7(1):6313.
Score: 0.182
-
Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia. Sci Rep. 2021 05 31; 11(1):11334.
Score: 0.059
-
Synergy Between Vitamin D and Sex Hormones in Respiratory Functionality of Patients Affected by COVID-19. Front Pharmacol. 2021; 12:683529.
Score: 0.059
-
Prolonged and severe SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: A tailored approach. Int J Infect Dis. 2021 Jun; 107:247-250.
Score: 0.059
-
No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison. Front Pharmacol. 2021; 12:621676.
Score: 0.059
-
Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital. Int J Infect Dis. 2021 Apr; 105:532-539.
Score: 0.058
-
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. Cell. 2021 04 01; 184(7):1821-1835.e16.
Score: 0.058
-
COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study. PLoS One. 2020; 15(12):e0244129.
Score: 0.058
-
Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases. Front Immunol. 2020; 11:610300.
Score: 0.057
-
Virus-Negative Myopericarditis in Human Coronavirus Infection: Report From an Autopsy Series. Circ Heart Fail. 2020 Nov 12; CIRCHEARTFAILURE120007636.
Score: 0.057
-
Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19. J Antimicrob Chemother. 2020 10 01; 75(10):2977-2980.
Score: 0.057